The Vi capsular polysaccharide vaccine (or ViCPS) is a typhoid vaccine recommended by the World Health Organization for the prevention of typhoid (another is Ty21a). The vaccine was first licensed in the US in 1994 and is made from the purified Vi capsular polysaccharide from the Ty2 Salmonella Typhi strain; it is a subunit vaccine.
Property | Value |
---|---|
dbo:abstract |
|
dbo:alternativeName |
|
dbo:casNumber |
|
dbo:wikiPageID |
|
dbo:wikiPageLength |
|
dbo:wikiPageRevisionID |
|
dbo:wikiPageWikiLink |
|
dbp:atcPrefix |
|
dbp:atcSuffix |
|
dbp:casNumber |
|
dbp:chemspiderid |
|
dbp:legalUs |
|
dbp:routesOfAdministration |
|
dbp:target | |
dbp:tradename |
|
dbp:type |
|
dbp:vaccineType |
|
dbp:verifiedfields |
|
dbp:verifiedrevid |
|
dbp:wikiPageUsesTemplate | |
dcterms:subject | |
rdf:type | |
rdfs:comment |
|
rdfs:label |
|
owl:sameAs | |
prov:wasDerivedFrom | |
foaf:isPrimaryTopicOf | |
is dbo:wikiPageRedirects of | |
is dbo:wikiPageWikiLink of | |
is foaf:primaryTopic of |